Facebook Linkedin RSS Twitter Youtube
Home 2024

Takeda Pharmaceutical Company

Lilly to Acquire Morphic for $3.2B, Adding Phase II IBD Programs
Drug Discovery

Lilly to Acquire Morphic for $3.2B, Adding Phase II IBD Programs

Alexandria Founder Talks Takeda, Massachusetts, NYC, and 30th Anniversary
Drug Discovery

Alexandria Founder Talks Takeda, Massachusetts, NYC, and 30th Anniversary

Lab Space Giant Alexandria Real Estate Navigates AI’s Impact on Biopharma
Artificial Intelligence

Lab Space Giant Alexandria Real Estate Navigates AI’s Impact on Biopharma

Light My Fire: COUR Raises $105M Series A to Advance Tolerogenic Nanoparticles for Autoimmunity
Drug Discovery

Light My Fire: COUR Raises $105M Series A to Advance Tolerogenic Nanoparticles for Autoimmunity

Schrödinger’s Equation: Physics + Machine Learning = Drug Discovery
Artificial Intelligence

Schrödinger’s Equation: Physics + Machine Learning = Drug Discovery

Rising Star: Vega Targets Rare Blood Disorders with Antibodies
GEN Edge

Rising Star: Vega Targets Rare Blood Disorders with Antibodies

Takeda Acquires Autoimmune Candidate from Nimbus for Up to $6B
Drug Discovery

Takeda Acquires Autoimmune Candidate from Nimbus for Up to $6B

Takeda Dengue Vaccine Recommended for Approval by European Committee
Drug Discovery

Takeda Dengue Vaccine Recommended for Approval by European Committee

Now Hiring: COVID-19, VC Surge Fuels Biotech Job Gains in Massachusetts and California
GEN Edge

Now Hiring: COVID-19, VC Surge Fuels Biotech Job Gains in Massachusetts and California

With Up-to-$3.6B Poseida Collaboration, Takeda Doubles Down on Gene Therapy
Drug Discovery

With Up-to-$3.6B Poseida Collaboration, Takeda Doubles Down on Gene Therapy

123...20Page 1 of 20
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.